Xelect is a leading aquaculture genetics services provider, based in St Andrews, Scotland. After a sustained period of rapid growth we are looking to recruit an additional Breeding Programme Manager to join our team.
Our Breeding Programme Managers are experienced aquaculture professionals who are responsible for developing and managing genetics-backed breeding programmes and carrying out consultancy for our global portfolio of customers.
With the support of our highly experienced laboratory, bioinformatics and genetics teams you will:
We currently operate a ‘hybrid’ working pattern, combining office days and working from home. The position comes with a competitive salary and will be based in St Andrews, Scotland.
Xelect is a leading aquaculture genetics service provider with a global portfolio of clients, including some of the biggest names in the industry. We employ a team of 17 staff, including a multidisciplinary technical team with 13 PhDs in aquaculture, quantitative genetics, bioinformatics, molecular biology and physiology. There are three business streams: breeding programme management, BioAudit & due diligence services and laboratory services. The business has its headquarters in the medieval university town of St Andrews on the East coast of Scotland some 80 km from Edinburgh airport. The company occupies modern office and laboratory facilities with 2 Illumina DNA sequencing machines. Breeding programme management is the largest business segment contributing 80% of revenues from customers in 20 countries dealing with 19 species of fish, shrimp and oysters.
The company has developed sophisticated industry-leading genetic and bioinformatic analysis pipelines including advanced mate selection software. The breeding service involves strategic partnerships with customers on rolling long-term contracts with a high level of project management support delivered from the UK and through customer visits. Revenues are in access of £2million/year and are growing at around 30% per annum. The company is profitable with good levels of cash flow. The shareholders in decreasing order of holding are Genus plc, Prof. Ian Johnston FRSE (current CEO and co-founder), the University of St Andrews, Dr Tom Ashton (Operations Director and co-founder) and the EOS Technology Investment Syndicate.’
To apply please send a current CV and a covering letter to email@example.com, along with contact details of two referees. References will only be contacted after a successful interview. If you would like to make any enquiries about the role please email firstname.lastname@example.org.